Therefore, higher BDNF levels in patients showing characteristics of an aggressive disease course could reflect insufficient repair mechanisms leading to apoptosis and permanent neuroaxonal damage and therefore persisting neurological deficits in patients with MS. The gene discussed is BDNF; the disease is myeloid sarcoma.